alexion pharmaceuticals inc
Ruedi E. Waeger Ph.D.
Former Independent Director, Chairman of Compliance & Quality Committee and Member of Compensation Committee, Alexion Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 11 board members in 2 different organizations across 2 different industries.|
See Board Relationships
Dr. Ruedi E. Waeger, Ph.D. served is the President and Chief Executive Officer of Aventis Behring L.L.C. Mr. Waeger served as President and Chief Executive Officer of ZLB Central Laboratory, Blood Transfusion Service for the Swiss Red Cross. He serves as Chairman of PharmaServ GmbH & Co. Mr. Waeger has been a Director of Eximias Pharmaceutical Corporation since June 6, 2005. Mr. Waeger is a Director of Talecris Biotherapeutics Holdings Corp. since April 2005 and YM BioSciences ...
352 Knotter DrivePhone: 203-272-2596
Cheshire, Connecticut 06410
Board Members Memberships*
Eidgenössische Technische Hochschule Zürich
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Rakesh Sachdev||Chief Executive Officer, President and Director|
|Stephen Edward Foots||Group Chief Executive, Executive Director, Chairman of Group Executive Committee, Member of Nomination Committee, Member of Routine Business Committee, Member of Group Safety, Health & Environment Steering Committee, Member of Finance Committee and Member of Risk Management Committee|
Croda International plc
|Heinz-Jurgen Bertram Ph.D.||Chairman of Executive Board, Chief Executive Officer and Labour Director|
|Gunupati Venkateswara Prasad B.Sc. (Chem. Eng.), M.S. (Indl. Admn.)||Co-Chairman, Chief Executive Officer, Managing Director, Member of the Management Council, Member of Management Committee, Member of Stakeholders' Relationship Committee, Member of Investment Committee and Member of Corporate Social Responsibility Committee|
Dr. Reddy's Laboratories Ltd.
|6.3M||Compensation as of Fiscal Year 2014.|